Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Donor Leukocyte Infusions (DLIs) for Recurrent Hodgkin Lymphoma (HL) Following Allogeneic Stem Cell Transplantation (allo-SCT): Ten-Year Experience at the M.D. Anderson Cancer Center

Paolo Anderlini, MD, Sandra Acholonu, Grace-Julia Okoroji, Sergio A Giralt, MD, Roy Jones, MD, PhD, Chitra M Hosing, MD, Muzaffar H Qazilbash, MD, Yago Nieto, MD, PhD, Borje S Andersson, MD, PhD, Uday R Popat, MD, Naoto T Ueno, MD, Marcos J de Lima, MD, Richard E Champlin, MD

Blood (2011) 118 (21): 4460.

https://doi.org/10.1182/blood.V118.21.4460.4460

Published: 2011

Journal Articles

Prediction of Apheresis Peripheral Blood Stem Cell Yield Based on Pre Apheresis Absolute Peripheral Blood Stem Cell Counts,

Blood (2011) 118 (21): 4047.

https://doi.org/10.1182/blood.V118.21.4047.4047

Published: 2011

Journal Articles

Mature Results of BEAM/High-Dose Rituximab Vs BEAM/Yttrium-90 Ibritumomab Tiuxetan (Zevalin ® ) and Autologous Stem Cell Transplantation (ASCT) for Relapsed CD20+ Follicular and Diffuse Large B-Cell Lymphoma: Survival Outcomes and Risk of Secondary Malignancies

Lisa Zipp, MS, Rima M Saliba, Ph.D., Rosamar Valverde, Grace-Julia Okoroji, Martin Korbling, MD, Barry I Samuels, MD, Lynne V. Abruzzo, MD, PhD, Amin M Alousi, MD, Borje S Andersson, MD, PhD, Chitra M Hosing, MD, Bill Erwin, MS, Paolo Anderlini, MD, Uday R Popat, MD, Partow Kebriaei, Homer A Macapinlac, MD, Richard Champlin, MD, Issa F. Khouri, MD

Blood (2011) 118 (21): 2005.

https://doi.org/10.1182/blood.V118.21.2005.2005

Published: 2011

Journal Articles

Autologous and Allogeneic Stem Cell Transplantation for T-Cell Lymphoma: The M.D. Anderson Cancer Center Experience,

Amer Beitinjaneh, MD, MPH, Rima M. Saliba, PhD, Grace-Julia Okoroji, Martin Korbling, MD, Amin M Alousi, MD, Uday Popat, MD, Paolo Anderlini, MD, Qaiser Bashir, MD, Borje S Andersson, MD, PhD, Partow Kebriaei, MD, Chitra M Hosing, MD, Muzaffar Qazilbash, MD, Michelle A. Fanale, MD, Barbara Pro, MD, Richard Champlin, MD, Issa Khouri, MD

Blood (2011) 118 (21): 4118.

https://doi.org/10.1182/blood.V118.21.4118.4118

Published: 2011

Journal Articles

Feasibility Analysis of Nonmyeloabltive Allogeneic Stem Cell Transplantation (NST) in Patients with Chronic Lymphocytic Leukemia (CLL) and 17p- Deletion,

Yvonne Hsu, Rima M Saliba, PhD, Grace-Julia Okoroji, Susan o'Brien, Alessandra Ferrajoli, MD, Lynne V. Abruzzo, MD, PhD, Richard Champlin, MD, Michael J Keating, MD, Issa F. Khouri, MD

Blood (2011) 118 (21): 4123.

https://doi.org/10.1182/blood.V118.21.4123.4123

Published: 2011

Journal Articles

12-Year Experience with High-Dose Rituximab-Containing Autologous Stem Cell Transplantation for SOX11-Positive Mantle Cell Lymphoma Patients in First Remission: Emerging Lymphoma-Free Survival Plateau After 3 Years,

Zaher I Chakhachiro, MD, Rima M Saliba, Ph.D., Grace-Julia Okoroji, Martin Korbling, MD, Amin M Alousi, MD, Chitra M Hosing, MD, Marcos De Lima, MD, Paolo Anderlini, MD, Uday Popat, M.D., Barry I Samuels, MD, L. Jeffrey Medeiros, MD, Carlos E. Bueso-Ramos, MD, PhD, Richard Champlin, MD, Issa F Khouri, MD

Blood (2011) 118 (21): 4138.

https://doi.org/10.1182/blood.V118.21.4138.4138

Published: 2011

Journal Articles

Human-Leukocyte-Histocompatibility Antigens Predict Response to Rituximab and Donor Lymphocyte Infusion (DLI) After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL)

Issa F. Khouri, Roland Bassett, Pedro Cano, Susan O'Brien, Yvonne Hsu, Carlos E. Bueso-Ramos, Robyn Harrell, Grace-Julia Okoroji, Leandro de Padua Silva, Alessandra Ferrajoli, Richard Champlin, John McMannis, Marcelo Fernandez-Vina

Blood (2010) 116 (21): 2548.

https://doi.org/10.1182/blood.V116.21.2548.2548

Published: 2010

Journal Articles

Outcome In Follicular Lymphoma (FL) Patients (pts) Relapsing After Autologous Stem Cell Transplantation (ASCT): Allografting Vs. Conventional Therapy

Grace-Julia Okoroji, Leandro de Padua Silva, Rima M Saliba, Martin Korbling, McLaughlin Peter, Chitra Hosing, Paolo Anderlini, Amin Alousi, Marcos de Lima, Partow Kebriaei, Uday Popat, Muzaffar Qazilbash, Luis Fayad, Felipe Samaniego, MD, MPH, Nathan Fowler, Richard Champlin, Fredrick Hagemeister, Issa F Khouri

Blood (2010) 116 (21): 3510.

https://doi.org/10.1182/blood.V116.21.3510.3510

Published: 2010

Journal Articles

Poor FEV1 or DLco on Pre-Transplant PFT Does Not Compromise Outcomes In Patients Undergoing a Reduced-Intensity Allogeneic Progenitor Cell Transplant.

Manish Sharma, MD, Rima M. Saliba, PhD, Muzaffar H. Qazilbash, MD, Grace-Julia Okoroji, Uday Popat, MD, Marcos de Lima, MD, Richard Champlin, Chitra Hosing, MD

Blood (2010) 116 (21): 1322.

https://doi.org/10.1182/blood.V116.21.1322.1322

Published: 2010

Journal Articles

Human-Leukocyte-Histocompatibility Antigens (HLA-A1+, A2-, B44-) and Serum Immunoglobulin (Ig)G with CD4 Levels Predict Response to Graft-Versus-Leukemia (GVL) and Overall Survival, Respectively, After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL).

Issa F Khouri, Roland L Bassett, Jr., Pedro Cano, Susan O'Brien, Yvonne Hsu, Carlos E Bueso-Ramos, Robyn Harrell, Grace-Julia Okoroji, Leandro De Padua Silva, Alessandra Ferrajoli, William Wierda, Hagop Kantarjian, Richard Champlin, John McMannis, Marcelo Fernandez-Vina

Blood (2009) 114 (22): 2287.

https://doi.org/10.1182/blood.V114.22.2287.2287

Published: 2009

Journal Articles

Autologous Stem Cell Mobilization with Cytokines and in-Vivo Alemtuzumab in Patients with T-Cell Non-Hodgkin's Lymphoma (T-NHL).

De Padua Silva Leandro, Rima Saliba, Donna McCormick, Grace-Julia Okoroji, Amin Alousi, Paolo Anderlini, Stefan Ciurea, Chitra Hosing, Partow Kebriaei, Uday Popat, Muzaffar Qazilbash, Naoto Ueno, John McMannis, Richard Champlin, Barbara Pro, Issa F Khouri

Blood (2009) 114 (22): 3213.

https://doi.org/10.1182/blood.V114.22.3213.3213

Published: 2009

Journal Articles

Stem Cell Transplantation with 90 yttrium Ibritumomab Tiuxetan( 90 YIT) in Non-Hodgkin's Lymphoma (NHL): Observations From PET Pre-Treatment Imaging and Responses in Allografted Refractory Follicular Histologies.

Blood (2009) 114 (22): 868.

https://doi.org/10.1182/blood.V114.22.868.868

Published: 2009

Journal Articles

Co-Morbidity Score at the Time of Transplant Determines Prognosis in Older Patients Who Develop Acute Graft-Vs.-Host Disease (GVHD).

Amin M Alousi, Gabriela Rondon, Grace-Julia Okoroji, Uday Popat, Leandro De Padua Silva, Sharon Hymes, Joyce Neumann, Nicole M Brunelle, Partow Kebriaei, Chitra Hosing, Issa F Khouri, Elizabeth J Shpall, Muzaffar H Qazilbash, Sergio Giralt, Richard Champlin, Rima M Saliba

Blood (2009) 114 (22): 2244.

https://doi.org/10.1182/blood.V114.22.2244.2244

Published: 2009

Journal Articles

Busulfan and Fludarabine Conditioning Regimen Negates the Impact of Comorbidity Score on Nonrelapse Mortality in Patients with AML/MDS

Uday Popat, MD, Rima Saliba, PhD, Leandro de Padua Silva, MD, Borje S Andersson, MD, PhD, Amin M Alousi, MD, Paolo Anderlini, MD, Marcos de Lima, MD, Grace-Julia Okoroji, MS, BS, Chitra M Hosing, MD, Roy B Jones, MD, PhD, Partow Kebriaei, MD, Issa Khouri, MD, Yago Nieto, MD, PhD, Muzaffar H Qazilbash, MD, Richard Champlin, MD, Sergio A Giralt, MD

Blood (2008) 112 (11): 799.

https://doi.org/10.1182/blood.V112.11.799.799

Published: 2008

Journal Articles

Prognostic Factors after Nonmyeloablative Allogeneic Stem Transplantation (NST) in Chronic Lymphocytic Leukemia (CLL): Expression of P53 May Not Predict Survival.

Issa Khouri, Roland L Bassett, Yvonne Hsu, Timothy Dickason, Sandra Acholonu, Robyn Harrell, Grace-Julia Okoroji, Leandro de Padua Silva, Martin J. Korbling, Amin M. Alousi, Chitra Hosing, Uday Popat, Sergio A. Giralt, Partow Kebriaei, Muzaffar H. Qazilbash, M.D., Celina Ledesma, Michael J. Keating, MB, BS, Richard E. Champlin, Carlos Bueso-Ramos

Blood (2008) 112 (11): 1128.

https://doi.org/10.1182/blood.V112.11.1128.1128

Published: 2008

Journal Articles

Addition of Rituximab to Mobilization and Conditioning Overcomes the Predictive Value of Follicular Lymphoma International Prognostic Index (FLIPI) Score in Patients with Relapsed FL Undergoing Autologous Stem Cell Transplantation (AUTO).

Issa F Khouri, M.D., Roland Bassett, Barry Samuels, Farzaneh Maadani, Grace-Julia Okoroji, Robyn Harrell, Martin Korbling, Leandro de Padua Silva, Amin Alousi, Chitra Hosing, Sergio Giralt, Marcos de Lima, Paolo Anderlini, Uday Popat, Rosamar Valverde, Yvonne Hsu, Fredrick Hagemeister, Peter McLaughlin, L. Jeffrey Medeiros

Blood (2008) 112 (11): 1140.

https://doi.org/10.1182/blood.V112.11.1140.1140

Published: 2008

Journal Articles

Myeloablative Chemotherapy for T-Cell Lymphoma: a Case for Autologous Stem Cell Transplantatin (Auto) in First Remission.

Issa F Khouri, Adriana Lopez, Grace-Julia Okoroji, Martin Korbling, MD, Gloria McCormick, Yvonne Hsu, Leandro de Padua, Amin M. Alousi, Chitra M. Hosing, Partow Kebriaei, MD, Gabriela Rondon, Sergio A Giralt, MD, Marcos J. de Lima, Paolo Anderlini, Uday R Popat, Muzaffar H. Qazilbash, Richard E. Champlin, Barbara Pro

Blood (2008) 112 (11): 1141.

https://doi.org/10.1182/blood.V112.11.1141.1141

Published: 2008

Journal Articles

Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease.

Blood (2008) 112 (11): 1142.

https://doi.org/10.1182/blood.V112.11.1142.1142

Published: 2008

Journal Articles

Efficacy and Safety of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

Blood (2006) 108 (11): 315.

https://doi.org/10.1182/blood.V108.11.315.315

Published: 2006

Journal Articles

The Influence of PET/Gallium (PET/Gal) Status and High-Dose Rituximab (HDR) in Patients with Aggressive, Large, B-Cell Lymphoma (LBCL) Receiving Autologous Stem Cell Transplants (ASCT).

Amin M. Alousi, MD, Rima M. Saliba, PhD, Grace-Julia Okoroji, MS, BS, Chitra Hosing, M.D., Barry I. Samuels, M.D., Richard E. Champlin, M.D., Issa F. Khouri, M.D.

Blood (2006) 108 (11): 3058.

https://doi.org/10.1182/blood.V108.11.3058.3058

Published: 2006

NARROW

Donor Leukocyte Infusions (DLIs) for Recurrent Hodgkin Lymphoma (HL) Following Allogeneic Stem Cell Transplantation (allo-SCT): Ten-Year Experience at the M.D. Anderson Cancer Center

Prediction of Apheresis Peripheral Blood Stem Cell Yield Based on Pre Apheresis Absolute Peripheral Blood Stem Cell Counts,

Mature Results of BEAM/High-Dose Rituximab Vs BEAM/Yttrium-90 Ibritumomab Tiuxetan (Zevalin ® ) and Autologous Stem Cell Transplantation (ASCT) for Relapsed CD20+ Follicular and Diffuse Large B-Cell Lymphoma: Survival Outcomes and Risk of Secondary Malignancies

Autologous and Allogeneic Stem Cell Transplantation for T-Cell Lymphoma: The M.D. Anderson Cancer Center Experience,

Feasibility Analysis of Nonmyeloabltive Allogeneic Stem Cell Transplantation (NST) in Patients with Chronic Lymphocytic Leukemia (CLL) and 17p- Deletion,

12-Year Experience with High-Dose Rituximab-Containing Autologous Stem Cell Transplantation for SOX11-Positive Mantle Cell Lymphoma Patients in First Remission: Emerging Lymphoma-Free Survival Plateau After 3 Years,

Human-Leukocyte-Histocompatibility Antigens Predict Response to Rituximab and Donor Lymphocyte Infusion (DLI) After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL)

Outcome In Follicular Lymphoma (FL) Patients (pts) Relapsing After Autologous Stem Cell Transplantation (ASCT): Allografting Vs. Conventional Therapy

Poor FEV1 or DLco on Pre-Transplant PFT Does Not Compromise Outcomes In Patients Undergoing a Reduced-Intensity Allogeneic Progenitor Cell Transplant.

Human-Leukocyte-Histocompatibility Antigens (HLA-A1+, A2-, B44-) and Serum Immunoglobulin (Ig)G with CD4 Levels Predict Response to Graft-Versus-Leukemia (GVL) and Overall Survival, Respectively, After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL).

Autologous Stem Cell Mobilization with Cytokines and in-Vivo Alemtuzumab in Patients with T-Cell Non-Hodgkin's Lymphoma (T-NHL).

Stem Cell Transplantation with 90 yttrium Ibritumomab Tiuxetan( 90 YIT) in Non-Hodgkin's Lymphoma (NHL): Observations From PET Pre-Treatment Imaging and Responses in Allografted Refractory Follicular Histologies.

Co-Morbidity Score at the Time of Transplant Determines Prognosis in Older Patients Who Develop Acute Graft-Vs.-Host Disease (GVHD).

Busulfan and Fludarabine Conditioning Regimen Negates the Impact of Comorbidity Score on Nonrelapse Mortality in Patients with AML/MDS

Prognostic Factors after Nonmyeloablative Allogeneic Stem Transplantation (NST) in Chronic Lymphocytic Leukemia (CLL): Expression of P53 May Not Predict Survival.

Addition of Rituximab to Mobilization and Conditioning Overcomes the Predictive Value of Follicular Lymphoma International Prognostic Index (FLIPI) Score in Patients with Relapsed FL Undergoing Autologous Stem Cell Transplantation (AUTO).

Myeloablative Chemotherapy for T-Cell Lymphoma: a Case for Autologous Stem Cell Transplantatin (Auto) in First Remission.

Rituximab Containing Autologous Stem Cell Transplantation May Be Curative in Mantle Cell Lymphoma for Patients in First Remission, but Not for Patients with Recurrent Disease.

Efficacy and Safety of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan in Autologous and Nonmyeloablative Stem Cell Transplantation (NST) for Relapsed Non-Hodgkin’s Lymphoma (NHL).

The Influence of PET/Gallium (PET/Gal) Status and High-Dose Rituximab (HDR) in Patients with Aggressive, Large, B-Cell Lymphoma (LBCL) Receiving Autologous Stem Cell Transplants (ASCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only